Wells Fargo’s Novo Nordisk NVO Stock Holding History

Wells Fargo’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,000	Closed	-$2.15M	–	7192
2024 Q4	$2.15M	Hold	25,000	–	–	﹤0.01%	3141
2024 Q3	$2.98M	Hold	25,000	–	–	﹤0.01%	2760
2024 Q2	$3.57M	Hold	25,000	–	–	﹤0.01%	2522
2024 Q1	$3.21M	Sell	25,000 -13,000	-34%	-$1.55M	﹤0.01%	2603
2023 Q4	$3.93M	Sell	38,000 -1,800	-5%	-$178K	﹤0.01%	2394
2023 Q3	$3.62M	Buy	+39,800	New	+$3.51M	﹤0.01%	2344
2020 Q2	–	Sell	-58,200	Closed	-$113K	–	6649
2020 Q1	$113K	Buy	+58,200	New	+$1.73M	﹤0.01%	5000

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Wells Fargo's NVO Position: Q1 2026 in Review

Wells Fargo reduced its Novo Nordisk (NVO) stake by 8.8% in Q1 2026, selling an estimated $16.6M and leaving 3,642,599 shares worth $134M. The position accounts for 0.03% of the portfolio, ranked #525.

Wells Fargo first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $583M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Wells Fargo held 3,642,599 shares of Novo Nordisk worth $134M as of Q1 2026.
Wells Fargo sold 349,450 Novo Nordisk shares in Q1 2026, an estimated $16.6M.
Novo Nordisk made up 0.03% of Wells Fargo's portfolio in Q1 2026, its #525 holding.
Wells Fargo first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
Wells Fargo's Novo Nordisk position peaked at $583M in Q2 2024.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.